Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Zhongguang Luo"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Immunotherapy had shown good antitumor activity in a variety of solid tumors, but low benefit in CRC, so there was an urgent need to explore new biomarkers. We evaluated the role of KMT2C using publicly available data from the Cancer Genome
Externí odkaz:
https://doaj.org/article/3fad1924f5b849a78d165fd2f2a33046
Autor:
Zhongguang Luo, Bangting Wang, Feifei Luo, Yumeng Guo, Ning Jiang, Jinsong Wei, Xin Wang, Yujen Tseng, Jian Chen, Bing Zhao, Jie Liu
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Background Colorectal adenoma (CA), especially high-risk CA (HRCA), is a precancerous lesion with high prevalence and recurrence rate and accounts for about 90% incidence of sporadic colorectal cancer cases worldwide. Currently, recurrent CA
Externí odkaz:
https://doaj.org/article/d50a81707766421eaab8bc398632e684
Autor:
Shaocong Mo, Bryan Jin, Yujen Tseng, Lingxi Lin, Lishuang Lin, Xin Shen, Huan Song, Mingjia Kong, Zhongguang Luo, Yiwei Chu, Chen Jiang, Zhiwei Cao, Jie Liu, Feifei Luo
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-18 (2023)
Abstract Background and Aims We sought to identify novel molecular subtypes of ulcerative colitis (UC) based on large-scale cohorts and establish a clinically applicable subtyping system for the precision treatment of the disease. Methods Eight micro
Externí odkaz:
https://doaj.org/article/5fde9161b21141479943da05ca266e55
Autor:
Yujen Tseng, Lingxi Lin, Shaocong Mo, Suhan Zhao, Qiwei Shen, Huan Song, Haoshu Cui, Jun Zhang, Wanwei Zheng, Zhongguang Luo, Feifei Luo, Jie Liu
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 11, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/c9b24bc00f47478795e52875985329c5
Autor:
Xue Wang, Wanwei Zheng, Qing Shen, Yahua Wang, Yujen Tseng, Zhongguang Luo, Xiaoyou Wang, Lei Shi, Chong Li, Jie Liu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/6ad7813d730841c9a25a996129c913a4
Publikováno v:
Gastroenterology Research and Practice, Vol 2021 (2021)
Externí odkaz:
https://doaj.org/article/da5154c65fbc424ead5e735e2825bf41
Hypoxia-inducible factor-1 (HIF-1) plays a critical role in reprogramming cancer metabolism toward aerobic glycolysis (i.e., the Warburg effect), which is critical to supplying cancer cells with the biomass needed for proliferation. Previous studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfe8657fa73b5274aecdddddee1c647
https://doi.org/10.1158/1535-7163.c.6535615.v1
https://doi.org/10.1158/1535-7163.c.6535615.v1
PDF - 218KB, Knockdown of LDH-A overcame resistance to cetuximab-induced cell cycle arrest.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ff8eaccc3f32fb36aa565545e2aea3
https://doi.org/10.1158/1535-7163.22497433.v1
https://doi.org/10.1158/1535-7163.22497433.v1
PDF - 190KB, Combination of oxamate and cetuximab induces growth inhibition in cetuximab-resistant HNSCC cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9e9ea5935e725d06c92ad74ae301e6d
https://doi.org/10.1158/1535-7163.22497430
https://doi.org/10.1158/1535-7163.22497430
Autor:
Jing Li, Wanwei Zheng, Jie Wu, Jun Zhang, Bin Lv, Wenshuai Li, Jie Liu, Xin Zhang, Tiansheng Huang, Zhongguang Luo
Publikováno v:
Acta Biochimica et Biophysica Sinica.